1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
2026 SURF/STAR program orientation May 26, 2026; Summer Symposium July 31, 2026. No specific application deadline for DRPP faculty grants stated.
Rhode Island IDeA Network of Biomedical Research Excellence (RI-INBRE) is sponsored by National Institutes of Health (NIH). The RI-INBRE program, funded by NIH, expands statewide research capacity in biomedical sciences, including cancer. This recent award supports equipment, workforce development, and recruitment of biomedical researchers and scientists in Rhode Island academic institutions.
Get alerted about grants like this
Get emailed when new opportunities from “National Institutes of Health (NIH)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Rhode Island IDeA Network of Biomedical Research Excellence – (RI-INBRE) 2026 WDT Registration is Open.
Event Date Time and Location Registration 2026 SURF/STAR Orientation May 26, 2026 9:30 AM – 4:00 PM 2026 RI-INBRE Annual Retreat June 26, 2026 1:30 PM – 3:30 PM Avedesian 240 Invitation Only 2026 Undergraduate Experience Day and Picnic June 26, 2026 9:00 AM – 3:00 PM 2026 Workforce Development and Training Panel Discussion July 15, 2026 12:00 PM – 2:00 PM Avedesian 240 2026 Summer Undergraduate Research Symposium (SURS) July 31, 2026 9:00 AM – 12:30 PM Link The Rhode Island IDeA Network of Biomedical Research Excellence (RI-INBRE) program is a statewide network designed to build the biomedical research capacity of Rhode Island institutions, by supporting and developing talented individuals committed to biomedical research careers in Rhode Island.
Research conducted under the RI-INBRE Developmental Research Project Program ( DRPP ) spans the breadth of biomedical sciences, including psychology, biomedical engineering, cancer biology, microbiology, microplastics, neurodegenerative diseases, cardiovascular health, and biomedical data science.
RI-INBRE hosts manages two core facilities for data acquisition and data analysis, the Centralized Research Core Facility ( CRCF ) and the Molecular Informatics Core ( MIC ). The SURF & STAR programs under the Training Core provide valuable research training experiences for undergraduate students.
The Institutional Development Award (IDeA) Network of Biomedical Research Excellence (INBRE) is designed to provide funding for building research capacity in selected states.
The guiding principles in organizing this Network for the development of biomedical sciences research in Rhode Island are to: Facilitate and increase the number of junior investigators and to prepare them to successfully compete for independent extramural funding from the NIH and other funding agencies Increase the number of students being trained for careers in the biomedical sciences Provide access to instrumentation and bioinformatics core facilities for conducting cutting-edge research Please direct any comments or questions regarding the RI-INBRE Program to riinbre@etal.
uri. edu Explore and Apply for Research Funding for Faculty Undergraduate, Graduate, and Faculty Fellowships RI Summer Undergraduate Research Symposium As Rhode Island’s flagship public research university, I am so proud to have INBRE’s home right here at URI, and I am proud that our work is being recognized at the federal level. It’s a true collaboration between all our colleges and universities.
URI President Marc Parlange The ten participating research institutions are the University of Rhode Island , Brown University , Bryant University , Johnson and Wales University , Providence College , Rhode Island College , Roger Williams University , Salve Regina University , Community College of Rhode Island and The New England Institute of Technology .
RI-INBRE is based at the University of Rhode Island and is located at the College of Pharmacy .
According to the current listing, eligibility includes: Academic institutions and researchers (undergraduate, graduate, faculty) at the ten Rhode Island institutions in the RI-INBRE network. Confirm the full requirements in the official notice before applying.
Rhode Island IDeA Network of Biomedical Research Excellence (RI-INBRE) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Rhode Island. If your organization operates elsewhere, check the official notice for location requirements.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
NIH R25 Summer Research Education Experience Program is a grant from the National Institutes of Health (NIH) that funds universities and institutions of higher education to provide summer research experiences in environmental health sciences to high school students, college undergraduates, and science teachers. Administered through the National Institute of Environmental Health Sciences (NIEHS), the program aims to attract young people to scientific careers and help teachers communicate about the scientific process more effectively. Eligible applicants are U.S. institutions eligible for NIH grants. The application deadline was March 17, 2026.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
As of October 1, 2025, NIH no longer posts Notices of Funding Opportunity in the NIH Guide — Grants.gov is now the single official source (NOT-OD-25-143). The weekly Guide table-of-contents email that thousands of investigators relied on to discover funding no longer lists opportunities. Combined with the January 25, 2026 SciENcv certified-PDF requirement, the mechanics of finding and applying for NIH money have changed underneath everyone. Here is how to rebuild your discovery workflow so nothing slips through.
Read articleThe HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleThe NIH Director's New Innovator Award (DP2, RFA-RM-27-002) closes August 17, 2026, offering roughly 30 Early Stage Investigators up to $475,000 in direct costs a year for five years — $2.375 million total — to pursue bold ideas without the preliminary data a standard R01 demands. Here is how the High-Risk, High-Reward program actually evaluates applications, who qualifies, and why the usual R01 instincts will sink you.
Read article